Leveraging Evolutionary Immunology in Interleukin-6 and Interleukin-17 Signaling for Lung Cancer...
Date : 25 Nov 2024
Khilwani R, Singh S.* Leveraging Evolutionary Immunology in Interleukin-6 and Interleukin-17 Signaling for Lung Cancer Therapeutics. ACS Pharmacology & Translational Science. November 22. 2024. https://doi.org/10.1021/acsptsci.4c00412.